ERBB2 and breast cancer: Preclinical Comparison of [111In]In- and[225Ac]Ac-DOTA-Trastuzumab IgG, F(ab′)2 and Fab for Theranostic SPECT/CT Imaging and α-ParticleRadioimmunotherapy of HER2-Positive Human Breast Cancer